The efficacy of degrading the androgen receptor through dermal application in DP cells, a deliverysystem for topical drugs that involves dissolving microneedles, and rosemary oil as an alternative anti-androgen.
Liposomal formulations of finasteride and minoxidil may enhance drugdelivery to the skin and hair follicles more effectively than traditional solutions, potentially improving treatment outcomes. However, more human clinical trials are needed to confirm these benefits.
A gel of keratin microspheres promotes hair follicle growth, showing similar effectiveness to minoxidil in mice. The treatment activates hair growth pathways and reduces inflammation, with potential applications in drugdelivery for hair-related disorders.
The conversation discusses the idea of creating finasteride gummies for hair loss treatment, with some users expressing skepticism about their effectiveness compared to pills. Concerns include the potential for reduced drugdelivery in gummy form and the risk of children mistaking them for candy.
Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.